Proof of Usefulness Report

C4U Corporation

Analysis completed on 2/14/2026

+330
Proof of Usefulness Score
Certified Problem Solver

C4U Corporation is a legitimate biotechnology venture from Osaka University specializing in CRISPR-Cas3 genome editing, a valid and high-potential technology. However, the submission itself is of extremely poor quality, containing demonstrable falsehoods (e.g., claiming 'most people have used my product' and 'audience reach: everyone') and vague financials ('marketcap: 2500000'). While the underlying technology and company existence were verified via external search (confirming Series B funding and team size), the score is heavily penalized due to the unreliable and unprofessional submission data.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+150.0
Audience Reach Impact+10.0
Technical Innovation+135.0
Evidence Of Traction+25.0
Market Timing Relevance+80.0
Functional Completeness+2.5
Subtotal+402.5
Usefulness Multiplierx0.82
Final Score+330

Project Details

Project URL
Description
C4U is a biotechnology venture company from Osaka University, engaging in research and development of novel genome editing technology, CRISPR-Cas3. Utilizing newly invented cutting-edge genome editing technology, C4U promotes the development of new treatments for various diseases, including genetic diseases. C4U also collaborates with other companies and is working to develop platforms for applications in other industries.

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline